1. Home
  2. TPCS vs CALC Comparison

TPCS vs CALC Comparison

Compare TPCS & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPCS
  • CALC
  • Stock Information
  • Founded
  • TPCS 1956
  • CALC 2011
  • Country
  • TPCS United States
  • CALC United States
  • Employees
  • TPCS N/A
  • CALC N/A
  • Industry
  • TPCS Metal Fabrications
  • CALC Biotechnology: Pharmaceutical Preparations
  • Sector
  • TPCS Industrials
  • CALC Health Care
  • Exchange
  • TPCS Nasdaq
  • CALC Nasdaq
  • Market Cap
  • TPCS 42.6M
  • CALC 22.9M
  • IPO Year
  • TPCS N/A
  • CALC N/A
  • Fundamental
  • Price
  • TPCS $3.69
  • CALC $1.58
  • Analyst Decision
  • TPCS
  • CALC Strong Buy
  • Analyst Count
  • TPCS 0
  • CALC 3
  • Target Price
  • TPCS N/A
  • CALC $16.33
  • AVG Volume (30 Days)
  • TPCS 29.2K
  • CALC 28.9K
  • Earning Date
  • TPCS 04-08-2025
  • CALC 08-11-2025
  • Dividend Yield
  • TPCS N/A
  • CALC N/A
  • EPS Growth
  • TPCS N/A
  • CALC N/A
  • EPS
  • TPCS N/A
  • CALC N/A
  • Revenue
  • TPCS $33,154,058.00
  • CALC N/A
  • Revenue This Year
  • TPCS N/A
  • CALC N/A
  • Revenue Next Year
  • TPCS N/A
  • CALC N/A
  • P/E Ratio
  • TPCS N/A
  • CALC N/A
  • Revenue Growth
  • TPCS 8.71
  • CALC N/A
  • 52 Week Low
  • TPCS $2.05
  • CALC $1.42
  • 52 Week High
  • TPCS $4.42
  • CALC $5.97
  • Technical
  • Relative Strength Index (RSI)
  • TPCS 55.11
  • CALC 44.94
  • Support Level
  • TPCS $3.36
  • CALC $1.42
  • Resistance Level
  • TPCS $3.85
  • CALC $1.85
  • Average True Range (ATR)
  • TPCS 0.25
  • CALC 0.15
  • MACD
  • TPCS 0.01
  • CALC -0.01
  • Stochastic Oscillator
  • TPCS 67.50
  • CALC 37.21

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: